fbpx The challenge of recognizing and managing complications of advanced Parkinson’s disease | Progress In Mind

The challenge of recognizing and managing complications of advanced Parkinson’s disease

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References

1. Antonini A et al. Wearing-off scales in Parkinson's disease: critique and recommendations. Mov Disord. 2011;26(12):2169-75.

2. Aleksovski D et al. Disease progression in Parkinson subtypes: the PPMI dataset. Neurol Sci. 2018;39(11):1971-6.

3. Antonini A et al. Medical and surgical management of advanced Parkinson's disease. Mov Disord. 2018;33(6):900-8.

4. Politis M et al. Parkinson’s disease symptoms: the patient’s perspective. Mov Disord. 2010;25(11):1646-51.

5. Martinez-Martin P et al. Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease. Mov Disord. 2016;31(3):270-9.

6. Martinez-Martin P et al. Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease. Parkinsonism Relat Disord. 2015;21(6):629-34.

7. Rodríguez-Violante M et al. Motor and non-motor wearing-off and its impact in the quality of life of patients with Parkinson's disease. Arq Neuropsiquiatr. 2018;76(8):517-21.

8. Schmitt E et al. The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A pilot study. Mov Disord Clin Pract. 2018;5(3):265-72.

9. Seppi K et al. Update on treatments for nonmotor symptoms of Parkinson’s disease - an evidence-based medicine review. Mov Disord. 2019;34(2):180-98.

10. Mirelman A et al. Gait impairments in Parkinson's disease. Lancet Neurol. 2019;18(7):697-708.

11. Schrag A et al. Predicting diagnosis of Parkinson’s Disease: A risk algorithm based on primary care presentations. Mov Disord. 2019;34(4):480-6.

12. Friederich A et al. Prodromal features of Parkinson's disease: Self-reported symptoms versus clinically assessed signs. Mov Disord. 2019;34(1):144-146.

13. Chastan N and Decker LM. Posturo-locomotor markers of preclinical Parkinson's disease. Neurophysiol Clin. 2019;49(2):173-80.

14. Müller MLTM et al. Treatment options for postural instability and gait difficulties in Parkinson's disease. Expert Rev Neurother. 2019 Aug 30:1-23. doi: 10.1080/14737175.2019.1656067.

You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country